zinc oxide has been researched along with gemcitabine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, W; Hu, C | 1 |
| Erk, N; Karimi-Maleh, H | 1 |
2 other study(ies) available for zinc oxide and gemcitabine
| Article | Year |
|---|---|
Zinc oxide nanoparticles (ZnO NPs) combined with cisplatin and gemcitabine inhibits tumor activity of NSCLC cells.
Topics: A549 Cells; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Drug Carriers; Gemcitabine; Humans; Lung Neoplasms; Metal Nanoparticles; Mice; Xenograft Model Antitumor Assays; Zinc Oxide | 2020 |
Gemcitabine drug intercalation with ds-DNA at surface of ds-DNA/Pt-ZnO/SWCNTs/GCE biosensor: A DNA-biosensor for gemcitabine monitoring confirmed by molecular docking study.
Topics: Biosensing Techniques; DNA; Electrochemical Techniques; Electrodes; Gemcitabine; Molecular Docking Simulation; Nanotubes, Carbon; Zinc Oxide | 2023 |